About API Pharma Tech
API Pharma Tech is a Healthcare company based in North Brunswick (United States) founded in 2016. It develops active pharmaceutical ingredients, formulations, and analytical services for global pharmaceutical markets. It operates on a B2B model. The company has 57 employees. Its Indian entity Energon Labs Private Limited reported revenue of ₹42.42 Cr. API Pharma Tech offers products and services including Contract Research Services, Formulation Development, API Process Development, and Contract Analytical Services. Its focus areas include Pharmaceutical Tech, API Development, Generic and Innovative APIs and Formulation Development.
Company details
API Pharma Tech specializes in developing and manufacturing active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). They provide contract research, formulation development, and analytical services while ensuring regulatory compliance. Operating from locations in the USA and India, they focus on high-quality therapeutic products and collaborate with manufacturers to deliver innovative solutions for the pharmaceutical industry.
- Headquarters North Brunswick, United States
- Employees 57
- SectorsHealthcare
- Website apipharmatech.com
- Social LinkedIn
- Legal Name Energon Labs Private Limited
- Date of Incorporation 26 Sep, 2018
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹42.42 Cr
FY 2024 · +48% YoY
- Indian entity net profit₹3.56 Cr
FY 2024 · 8% margin
- Indian entity EBITDA₹6.69 Cr
FY 2024 · 16% margin
- Employee Count57
Associated legal entities of API Pharma Tech
API Pharma Tech operates through Energon Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Energon Labs Private Limited CIN U73200TG2018PTC127126 | Active | 26 Sep 2018 | Hyderabad, Telangana | ₹42.4 Cr | 57 | 4 | View details |
Products & Services of API Pharma Tech
API Pharma Tech offers a comprehensive portfolio of products and services, including Contract Research Services, Formulation Development, API Process Development, and Contract Analytical Services.
Offers research for pharmaceutical development and innovation.
Develops formulations for therapeutic active ingredients.
Handles processes for active pharmaceutical ingredients production.
Provides testing and analysis for pharmaceutical quality control.
Board of directors of Energon Labs Private Limited (API Pharma Tech)
Energon Labs Private Limited is the primary company behind API Pharma Tech. The board of Energon Labs Private Limited currently have 4 directors; the longest-serving is Veeranna Singuluri, appointed in 2018. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Veeranna Singuluri DIN 06824501 | Director | 26 Sep 2018 | 8 yrs 1 mo | Energon Labs Private Limited |
| Surekha Maddula DIN 08258532 | Director | 30 Sep 2019 | 7 yrs 1 mo | Energon Labs Private Limited |
| Umamaheswar Siripurapu DIN 09379719 | Director | 28 Oct 2021 | 5 yrs | Energon Labs Private Limited |
| Manikanth Reddy Yarala DIN 08238920 | Additional Director | 22 Jan 2025 | 1 yr 9 mo | Energon Labs Private Limited |
Financials of API Pharma Tech
Figures of Energon Labs Private Limited, the primary company behind API Pharma Tech, for FY 2024. Revenue was ₹42.42 Cr (+48% year on year). Net profit was ₹3.56 Cr (8% margin). EBITDA was ₹6.69 Cr (16% margin). Revenue has grown at a compounded annual rate of +62% over three years.
- ₹42.42 CrRevenue · FY 2024 · +48% YoY
- ₹3.56 CrNet profit · 8% margin
- ₹6.69 CrEBITDA · 16% margin
- ₹1 LakhPaid-up capital
- 57Employees (provident fund records)
- +62%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Energon Labs Private Limited are on its company page.
Detailed financial statements for API Pharma Tech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as API Pharma Tech (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 61.16 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Api Pharma Tech
Complete news archive for API Pharma Tech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about API Pharma Tech
API Pharma Tech was founded in 2016.
API Pharma Tech is headquartered in North Brunswick, United States. It is registered at North Brunswick, New Jersey, United States.
API Pharma Tech has 57 employees.
The primary company behind API Pharma Tech, Energon Labs Private Limited, reported revenue of ₹42.42 Cr for FY 2024, up 48% year on year.
API Pharma Tech specializes in developing and manufacturing active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). They provide contract research, formulation development, and analytical services while ensuring regulatory compliance. Operating from locations in the USA and India, they focus on high-quality therapeutic products and collaborate with manufacturers to deliver innovative solutions for the pharmaceutical industry.
API Pharma Tech offers Contract Research Services, Formulation Development, API Process Development, and Contract Analytical Services.
API Pharma Tech operates through Energon Labs Private Limited.
The legal entities of API Pharma Tech currently have 4 directors, including Manikanth Reddy Yarala, Umamaheswar Siripurapu, Surekha Maddula and others.